We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Jul 2019 to Jul 2024
BUDAPEST--Hungarian energy group MOL Nyrt. (MOL.BU) is aiming to sign contracts for 225 billion forints ($1 billion) in new investments in the fourth quarter of this year, the company said late Monday.
MAIN FACTS:
-MOL is planning to invest a total of more than HUF300 billion in the next three years in Hungary to enhance its operation.
-MOL's board of directors decided to speed up the process and authorized the management to sign contracts for 75% of the allocated total as soon as the last quarter of 2012.
-MOL will carry out investment projects in exploration, production, refining as well as marketing.
-Half of the total sum will go to hydrocarbon exploration and field development, including unconventional exploration projects.
-"The currently extremely difficult industrial environment urges companies to become more flexible and constantly innovative... We have no choice but to outgrow the crisis: we want to regain our leading position among European refineries," MOL Chief Executive Jozsef Molnar said.
Write to the Budapest bureau at budapest@dowjones.com
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
